Oncology Testing Services
LabCorp Clinical Trials collaborates with all major oncology centers within the LabCorp specialty testing group as well as a European laboratory1 to provide comprehensive services in anatomic pathology, cytogenetics, immunohistochemistry, FISH, molecular oncology, and proprietary esoteric laboratory testing. These services are integrated into our global central safety laboratory testing, providing seamless management of international drug development efforts in oncology. Our professional clinical and scientific staff can provide consultative services for protocol design to ensure accurate and timely results for each study. LabCorp Clinical Trials offers innovative oncology testing solutions that assist our clients in reaching early and accurate decisions about their drug’s performance.
Flow Cytometry
- Antibody panels uniquely designed to identify specific liquid tumors
- Minimal residual disease detection and monitoring
- Intracellular cytokine (other proteins) assays
- Receptor occupancy assays (monoclonal therapies)
- Signal transduction/cell signaling (phospho-epitopes)
- Mitosis / DNA
- Rare event analysis (progenitor cells, dendritic cells, and tetramer analysis)
- Apoptosis (Caspase, Annexin V)
- Natural killer cell activity / ADCC activity
- Gene therapy analytical systems (examples MDM2, BAX, p21, p53 and others)
- Advanced cytometric applications in oncology (i.e., detection of phosphorylation pathway biomarkers for targeted therapeutics)
- Dedicated research and development team for assay development and validation